Epigen vs Teriparatide

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Epigen

Epigen is a member of the epidermal growth factor (EGF) family. It plays roles in skin regeneration and has been studied for wound healing and anti-aging applications.

Full details →

Teriparatide

Teriparatide (Forteo) is recombinant human parathyroid hormone (1-34), FDA-approved for osteoporosis treatment. It's unique among osteoporosis drugs in that it stimulates new bone formation.

Full details →

Side-by-Side Comparison

Aspect	Epigen	Teriparatide
Dose Range	100 mcg–500 mcg	20 mcg
Frequency	1x daily	1x daily
Cycle Length	4–8 weeks	52–104 weeks
Route	subcutaneous	subcutaneous
Mechanism	Binds to and activates the EGF receptor (EGFR), promoting cell proliferation, migration, and differentiation. Involved in skin homeostasis and repair processes.	Intermittent PTH exposure paradoxically stimulates osteoblasts more than osteoclasts, resulting in net bone formation. Continuous exposure would cause bone loss, but pulsatile dosing builds bone.
Typical Dosage	Topical: Typically used at low concentrations (ppm to low %) in cosmetic formulations. Research applications vary.	20mcg subcutaneously once daily. Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration	Primarily topical application for skincare. Research may use other routes for systemic effects.	Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Side Effects	Topical use generally well-tolerated. Theoretical concerns about promoting cell proliferation.	Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Best For	Recovery & Healing Skin Health & Aesthetics	Recovery & Healing